Vaccine News and Research

Latest Vaccine News and Research

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Collectively, malaria, TB & HIV/AIDS cause more than five million deaths per year - nearly the entire population of the state of Washington - and represent one of the world's major public health challenges as we move into the second decade of the 21st century.

26 May 2011

Doctors and nurses key to preventing vaccine refusal outbreaks

Well-informed doctors and nurses are the key to preventing parents refusing childhood immunisations because of vaccine scare campaigns, a University of Sydney expert writes in the latest edition of the international journal Nature.

25 May 2011

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.

25 May 2011

Russia spent more than $80M in health-related foreign aid in 2010, report says

The Russian Federation in 2010 spent more than $80 million to improve health in developing countries, according to a report prepared by the country's Ministry of Finance, which highlights "how the country is meeting its G8 commitments ahead of the upcoming summit in Deauville, France," the Moscow Times reports.

25 May 2011

Idera Pharmaceuticals' preclinical data on novel GSO technology presented at TIDES 2011

Idera Pharmaceuticals, Inc. today announced the presentation of preclinical data of its novel gene-silencing oligonucleotide technology including observations that demonstrate GSOs exert gene-silencing activity through a similar cellular pathway as siRNA.

25 May 2011

ImmunoCellular to present new ICT-107 Phase I trial data in glioblastoma multiforme at ASCO 2011

ImmunoCellular Therapeutics, Ltd today announced it will be presenting new data from the Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme.

25 May 2011

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

There's a wealth of health information hiding in the human immune system. Accessing it, however, can be very challenging, as the many and complex roles that the immune system plays can mask the critical information that is relevant to addressing specific health issues.

25 May 2011

Whooping cough on the rise mandates continuation of vaccine drive

A sharp rise in the number of whooping cough (Pertussis) cases has prompted the New South Wales Government to extend a free vaccine program until at least the end of the year. The health authorities say it is extremely important for infants and older children to be vaccinated on time.

24 May 2011

Small pox virus destruction pushed back to 2014

The last existing vials of smallpox virus in the U.S. and Russia and due for destruction, have won at least another three years in existence. This is suggesting other countries concur with the U.S. about their value, one leading health official said. The experts and delegates at the annual meeting of the World Health Organization agreed on Tuesday to wait until 2014 to decide on a firm deadline for the final destruction of the lethal virus.

24 May 2011

Largest number of measles cases in the US since 1996: Report

According to the latest report from the Centers for Disease Control and Prevention (CDC), the United States has had 118 measles cases so far this year, the most for this date since 1996, and close to 90% of them are linked to cases in other countries.

24 May 2011

New study shows that closing schools, other measures limited H1N1 spread in Mexico

The H1N1 virus was new, and most of the cases occurred among young people. Health professionals and scientists weren’t sure at the onset what the world would encounter with the virus.

24 May 2011

Accelerator announces Series A financing of Oncofactor

Accelerator Corporation, a privately held, venture-capital-backed biotechnology investment and development company, announced today the Series A financing of Oncofactor Corporation. This is the twelfth company backed by Accelerator and its first investment based on internal intellectual property developed at Accelerator.

24 May 2011

Study offers hope for reducing incidence of AIDS with potential preventive vaccine

The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization. Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.

24 May 2011

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

A team led by Thomas B. Nutman, M.D., of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has completed a large-scale analysis of most of the proteins produced by Brugia malayi, one kind of parasitic worm that causes lymphatic filariasis, or elephantiasis.

24 May 2011

Novel hepatitis C-like virus discovered in dogs

In a study to be published online this week in the Proceedings of the National Academy of Sciences, researchers report the discovery of a novel hepatitis C-like virus in dogs. The identification and characterization of this virus gives scientists new insights into how hepatitis C in humans may have evolved and provides scientists renewed hope to develop a model system to study how it causes disease.

24 May 2011

Novel compound could become an effective alternative to common narcotic analgesics

Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine.

23 May 2011

Leopoldina recommends improvements for global access to clean drinking water and sanitation to G8 states

Together with the national science academies of the other G8 states, the German National Academy of Sciences Leopoldina has prepared two statements for the G8 states in the run-up to the G8 Summit of Heads of State and Government.

21 May 2011

Walter and Eliza Hall Institute researcher selected Fellow of the Royal Society

Internationally recognised malaria researcher Professor Alan Cowman from the Walter and Eliza Hall Institute in Melbourne, Australia, has been elected a Fellow of the Royal Society, the UK's peak academy promoting excellence in science.

21 May 2011

Malian government to reimburse GAVI Alliance for grant money after joint investigation shows misuse

The GAVI Alliance on Thursday said an investigation conducted by a GAVI transparency and accountability team and auditors from the Malian government "has found that $563,000 was misused in two of its cash-based projects in Mali, and Malian authorities have agreed to pay it back," Reuters reports.

21 May 2011

Salk Institute researchers receive $5.5M Program Project Grant to analyze Williams syndrome

A multi-institutional team headed by Ursula Bellugi, professor and director of the Laboratory for Cognitive Neuroscience at the Salk Institute for Biological Studies, has been awarded a $5.5 million Program Project Grant by the National Institute of Child Health and Human Development to link social behavior to its underlying neurobiological and molecular genetic basis using Williams syndrome as a model.

21 May 2011

Vaccine News and Research

Latest Vaccine News and Research

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Doctors and nurses key to preventing vaccine refusal outbreaks

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

Russia spent more than $80M in health-related foreign aid in 2010, report says

Idera Pharmaceuticals' preclinical data on novel GSO technology presented at TIDES 2011

ImmunoCellular to present new ICT-107 Phase I trial data in glioblastoma multiforme at ASCO 2011

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

Whooping cough on the rise mandates continuation of vaccine drive

Small pox virus destruction pushed back to 2014

Largest number of measles cases in the US since 1996: Report

New study shows that closing schools, other measures limited H1N1 spread in Mexico

Accelerator announces Series A financing of Oncofactor

Study offers hope for reducing incidence of AIDS with potential preventive vaccine

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

Novel hepatitis C-like virus discovered in dogs

Novel compound could become an effective alternative to common narcotic analgesics

Leopoldina recommends improvements for global access to clean drinking water and sanitation to G8 states

Walter and Eliza Hall Institute researcher selected Fellow of the Royal Society

Malian government to reimburse GAVI Alliance for grant money after joint investigation shows misuse

Salk Institute researchers receive $5.5M Program Project Grant to analyze Williams syndrome

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Vaccine News and Research

Latest Vaccine News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in